{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:40:56Z","timestamp":1771558856599,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Policy"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1016\/s0168-8510(01)00233-0","type":"journal-article","created":{"date-parts":[[2002,10,14]],"date-time":"2002-10-14T17:55:05Z","timestamp":1034618105000},"page":"173-187","source":"Crossref","is-referenced-by-count":61,"title":["Productivity costs before and after absence from work: as important as common?"],"prefix":"10.1016","volume":"61","author":[{"given":"W.B.F","family":"Brouwer","sequence":"first","affiliation":[]},{"given":"N.J.A","family":"van Exel","sequence":"additional","affiliation":[]},{"given":"M.A","family":"Koopmanschap","sequence":"additional","affiliation":[]},{"given":"F.F.H","family":"Rutten","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0168-8510(01)00233-0_BIB1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1099-1050(199705)6:3<253::AID-HEC266>3.0.CO;2-6","article-title":"Productivity costs measurement through quality of life? A response to the recommendations of the US Panel","volume":"6","author":"Brouwer","year":"1997","journal-title":"Health Economics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO;2-K","article-title":"Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion","volume":"6","author":"Brouwer","year":"1997","journal-title":"Health Economics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1017\/S026646230001148X","article-title":"Patient and informal caregiver time in cost-effectiveness analysis. A response to recommendations of the US Panel","volume":"14","author":"Brouwer","year":"1998","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8510(99)00028-7","article-title":"Productivity losses without absence; measurement validation and empirical evidence","volume":"48","author":"Brouwer","year":"1999","journal-title":"Health Policy"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0167-6296(99)00038-7","article-title":"On the economic foundations of CEA. Ladies and gentlemen, take your positions","volume":"19","author":"Brouwer","year":"2000","journal-title":"Journal of Health Economics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB6","unstructured":"Drummond MF. Australian guidelines for cost-effectiveness studies of pharmaceuticals: The thin end of the boomerang? Centre for Health Economics Discussion paper 88, University of York, York, 1991."},{"key":"10.1016\/S0168-8510(01)00233-0_BIB7","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"1997"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB8","series-title":"Cost-effectiveness in health and medicine","year":"1996"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB9","series-title":"Health, health care and health economics: perspectives on distribution","article-title":"Welfarism, Extra-Welfarism and Evaluative Economic Analysis in the Health Care Sector","author":"Hurley","year":"1998"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00019053-199711050-00001","article-title":"Avoiding double-counting in pharmacoeconomic studies","volume":"11","author":"Johannesson","year":"1997","journal-title":"PharmacoEconomics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0277-9536(92)90131-9","article-title":"Towards a new approach for estimating indirect costs of disease","volume":"34","author":"Koopmanschap","year":"1992","journal-title":"Social Science and Medicine"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0167-6296(94)00044-5","article-title":"The friction cost method for measuring indirect costs of disease","volume":"14","author":"Koopmanschap","year":"1995","journal-title":"Journal of Health Economics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB13","first-page":"DS59","article-title":"Indirect costs: the consequences of production loss or increased costs of production","volume":"34","author":"Koopmanschap","year":"1996","journal-title":"Medical Care"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00019053-199202010-00008","article-title":"Health care resource and lost labor costs of migraine headache in the US","volume":"2","author":"Osterhaus","year":"1992","journal-title":"PharmacoEconomics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2165\/00019053-199507020-00008","article-title":"Societal perspective on the burden of migraine in the Netherlands","volume":"7","author":"van Roijen","year":"1995","journal-title":"PharmacoEconomics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1365-2036.1998.00376.x","article-title":"Estimating the cost of lost productivity in dyspepsia","volume":"12","author":"Severens","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/S0168-8510(01)00233-0_BIB17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/(SICI)1099-1050(199709)6:5<505::AID-HEC294>3.0.CO;2-I","article-title":"Productivity costs, time costs and health related quality of life: a response to the Erasmus Group","volume":"6","author":"Weinstein","year":"1997","journal-title":"Health Economics"}],"container-title":["Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168851001002330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168851001002330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T05:29:11Z","timestamp":1556429351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168851001002330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0168851001002330"],"URL":"https:\/\/doi.org\/10.1016\/s0168-8510(01)00233-0","relation":{},"ISSN":["0168-8510"],"issn-type":[{"value":"0168-8510","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}